Suppr超能文献

人类钙通道 2.2 型被痛觉阻断剂 ziconotide 阻断的结构。

Structure of human Ca2.2 channel blocked by the painkiller ziconotide.

机构信息

Department of Molecular Biology, Princeton University, Princeton, NJ, USA.

出版信息

Nature. 2021 Aug;596(7870):143-147. doi: 10.1038/s41586-021-03699-6. Epub 2021 Jul 7.

Abstract

The neuronal-type (N-type) voltage-gated calcium (Ca) channels, which are designated Ca2.2, have an important role in the release of neurotransmitters. Ziconotide is a Ca2.2-specific peptide pore blocker that has been clinically used for treating intractable pain. Here we present cryo-electron microscopy structures of human Ca2.2 (comprising the core α1 and the ancillary α2δ-1 and β3 subunits) in the presence or absence of ziconotide. Ziconotide is thoroughly coordinated by helices P1 and P2, which support the selectivity filter, and the extracellular loops (ECLs) in repeats II, III and IV of α1. To accommodate ziconotide, the ECL of repeat III and α2δ-1 have to tilt upward concertedly. Three of the voltage-sensing domains (VSDs) are in a depolarized state, whereas the VSD of repeat II exhibits a down conformation that is stabilized by Ca2-unique intracellular segments and a phosphatidylinositol 4,5-bisphosphate molecule. Our studies reveal the molecular basis for Ca2.2-specific pore blocking by ziconotide and establish the framework for investigating electromechanical coupling in Ca channels.

摘要

神经元型(N 型)电压门控钙(Ca)通道,被指定为 Ca2.2,在神经递质释放中起重要作用。Ziconotide 是一种 Ca2.2 特异性肽孔阻断剂,已在临床上用于治疗难治性疼痛。在这里,我们展示了存在或不存在 Ziconotide 时人类 Ca2.2(包括核心 α1 和辅助 α2δ-1 和 β3 亚基)的冷冻电子显微镜结构。Ziconotide 由 P1 和 P2 螺旋以及支持选择性过滤器的 α1 的重复 II、III 和 IV 的细胞外环(ECL)彻底协调。为了容纳 Ziconotide,重复 III 和 α2δ-1 的 ECL 必须协同向上倾斜。三个电压感应域(VSD)处于去极化状态,而重复 II 的 VSD 呈现出向下构象,该构象由 Ca2 独特的细胞内片段和磷脂酰肌醇 4,5-二磷酸分子稳定。我们的研究揭示了 Ziconotide 对 Ca2.2 特异性孔阻断的分子基础,并为研究 Ca 通道中的机电耦联奠定了框架。

相似文献

1
Structure of human Ca2.2 channel blocked by the painkiller ziconotide.
Nature. 2021 Aug;596(7870):143-147. doi: 10.1038/s41586-021-03699-6. Epub 2021 Jul 7.
2
Closed-state inactivation and pore-blocker modulation mechanisms of human Ca2.2.
Cell Rep. 2021 Nov 2;37(5):109931. doi: 10.1016/j.celrep.2021.109931.
3
Ziconotide: can we use it in palliative care?
Am J Hosp Palliat Care. 2005 Sep-Oct;22(5):369-74. doi: 10.1177/104990910502200510.
4
An integrated multiassay approach to the discovery of small-molecule N-type voltage-gated calcium channel antagonists.
Assay Drug Dev Technol. 2010 Dec;8(6):685-94. doi: 10.1089/adt.2010.0311. Epub 2010 Nov 4.
8
Ziconotide: a new option for refractory pain.
Drugs Today (Barc). 2006 Jun;42(6):369-78. doi: 10.1358/dot.2006.42.6.973534.
9
An orally available Ca2.2 calcium channel inhibitor for the treatment of neuropathic pain.
Br J Pharmacol. 2024 Jun;181(12):1734-1756. doi: 10.1111/bph.16309. Epub 2024 Feb 7.
10
The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels.
J Biol Chem. 2004 Aug 13;279(33):34705-14. doi: 10.1074/jbc.M310848200. Epub 2004 May 27.

引用本文的文献

1
Voltage-sensing domains: structural and functional diversity.
Eur Biophys J. 2025 Sep 13. doi: 10.1007/s00249-025-01797-1.
2
Molecular mechanism of ultrafast transport by plasma membrane Ca-ATPases.
Nature. 2025 Aug 20. doi: 10.1038/s41586-025-09402-3.
3
A Conceptual Review of Naturally Occurring Toxins and Venoms as Peptide Blockers to Combat Chronic Low Back Pain.
JOR Spine. 2025 Aug 15;8(3):e70107. doi: 10.1002/jsp2.70107. eCollection 2025 Sep.
5
Nonsubstrate PI(4,5)P interacts with the interdomain linker to control electrochemical coupling in voltage-sensing phosphatase (VSP).
Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2500651122. doi: 10.1073/pnas.2500651122. Epub 2025 Jul 29.
6
Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications.
Chem Rev. 2025 Aug 13;125(15):7099-7166. doi: 10.1021/acs.chemrev.4c00989. Epub 2025 Jul 23.
8
Neuronal ion channel modulation by Drimys winteri compounds: Opening a new chemical space to neuropharmacology.
Neural Regen Res. 2026 Apr 1;21(4):1373-1382. doi: 10.4103/NRR.NRR-D-24-01194. Epub 2025 Jun 19.
9
R and S enantiomers of CBD3063, a Ca2.2 N-type calcium channel modulator, alleviate capsaicin-induced inflammatory pain.
Neurobiol Pain. 2025 May 16;18:100185. doi: 10.1016/j.ynpai.2025.100185. eCollection 2025 Jul-Dec.
10

本文引用的文献

1
Comparative structural analysis of human Na1.1 and Na1.5 reveals mutational hotspots for sodium channelopathies.
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11). doi: 10.1073/pnas.2100066118.
4
Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca 1.1 by Dihydropyridine Compounds*.
Angew Chem Int Ed Engl. 2021 Feb 8;60(6):3131-3137. doi: 10.1002/anie.202011793. Epub 2020 Dec 10.
5
Structural Basis of Human KCNQ1 Modulation and Gating.
Cell. 2020 Jan 23;180(2):340-347.e9. doi: 10.1016/j.cell.2019.12.003. Epub 2019 Dec 26.
6
Structure of the Cardiac Sodium Channel.
Cell. 2020 Jan 9;180(1):122-134.e10. doi: 10.1016/j.cell.2019.11.041. Epub 2019 Dec 19.
7
Cryo-EM structures of apo and antagonist-bound human Ca3.1.
Nature. 2019 Dec;576(7787):492-497. doi: 10.1038/s41586-019-1801-3. Epub 2019 Nov 25.
8
Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca Channel.
Cell. 2019 May 30;177(6):1495-1506.e12. doi: 10.1016/j.cell.2019.04.043.
9
Structures of human Na1.7 channel in complex with auxiliary subunits and animal toxins.
Science. 2019 Mar 22;363(6433):1303-1308. doi: 10.1126/science.aaw2493. Epub 2019 Feb 14.
10
Molecular basis for pore blockade of human Na channel Na1.2 by the μ-conotoxin KIIIA.
Science. 2019 Mar 22;363(6433):1309-1313. doi: 10.1126/science.aaw2999. Epub 2019 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验